PACE/State of FL - Register now – Sept. 10, 2025

Clinically relevant overview of key genetic factors, testing strategies, and post-result care.

Conflict is a natural part of human interaction, and the workplace is not immune from that experience.  Through this microlearning, we'll explore how proper conflict[...]

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to welcome the new year and discuss the increase of respiratory viruses.

Becca Johnson, a dedicated project manager, joined Mayo Clinic in 2014, driven by a desire to contribute to an organization making a global impact. With BioPharma Diagnostics, Becca oversees large projects, ensuring efficient sample handling and timely client results. Committed to patient-centric care, she works on transitioning clients to electronic solutions for streamlined processes. Becca finds purpose in collaborative efforts that shape healthcare's future and positively impact patients' lives.

PACE/State of FL - This webinar will provide a methodology for laboratory leadership to review their test menu for assays that most impact the financial health of their laboratory.

There is a major weather system moving across the United States that may impact specimen transport. Winter storm Finn is expected to spread snow, strong winds, and create possible blizzard conditions into the Plains and Midwest. This may impact courier pickups and cause delays at major hubs (Fed Ex and UPS). We are monitoring and tracking this situation with our logistics partners and are prepared to adjust to minimize challenges. Clients should expect to be contacted directly by the couriers should any routes be modified or canceled.

Mayo Clinic Laboratories is excited to announce our participation in Medlab Middle East 2024, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 5–8, 2024.

This week's research roundup feature: To describe a 41-year-old woman with a history of neonatal onset multisystem inflammatory disease, on treatment with daily subcutaneous injections of 600 mg of recombinant interleukin-1 receptor antagonist (IL-1Ra) protein, anakinra, since the age of 28, who presented with golf-ball size nodules at the anakinra injection sites, early satiety, new onset nephrotic syndrome in the context of normal markers of systemic inflammation.

On the brink of losing her battle with acute myeloid leukemia, Shannon Camlek arrived at Mayo Clinic as a last hope. Her chances didn’t look good, but with the help of specialized genetic testing, particularly FISH (fluorescence in situ hybridization) studies, doctors were able to detect the specific gene mutations responsible for her symptoms and disease. The test results also helped Shannon’s care team target her treatment accordingly, and finally put an end to what Shannon likens as starring in her own personal horror movie while in search of hope and healing.

Recognizing the significance of eudaimonic well-being in the workplace is essential for employers, as fostering a sense of purpose and fulfillment among employees not only enhances individual satisfaction but also contributes to a positive and resilient organizational culture, ultimately driving long-term success and employee engagement.

Understanding the concept of burnout cascade is paramount for employers, as it not only directly affects the well-being of individual employees but also has the potential to permeate through entire teams, impacting overall productivity, morale, and organizational success.

Recognizing the signs of burnout in your employees is key. Taking action early not only boosts their well-being but also prevents serious health and career consequences down the road.

In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., engages in a compelling conversation with Lindsey Randall, a third-year medical student, as they discuss her experiences and insights in the role of a teaching assistant.

Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost cardiovascular risk.